STOCK TITAN

Royalty Pharma officer proposes $1.66M share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Royalty Pharma plc (RPRX) officer Christopher Hite reported a proposed sale of 30,000 Class A ordinary shares, with an aggregate market value of $1,660,500 and an approximate sale date of June 23, 2026. The shares were acquired from the issuer on June 18, 2020, through its IPO - Reserved Shares Program. The proposed sale is connected to a selling plan dated March 20, 2026, intended to comply with Rule 10b5-1(c).

Shares proposed for sale 30,000 Class A ordinary shares Approximate sale date: June 23, 2026
Aggregate market value $1,660,500 Proposed sale
Shares outstanding 443,274,104 shares Issuer's Class A ordinary shares
Selling plan date March 20, 2026 Plan intended to comply with Rule 10b5-1(c)
Acquisition date June 18, 2020 30,000 Class A ordinary shares acquired from the issuer through its IPO - Reserved Shares Program
Rule 10b5-1(c) regulatory
"intended to comply with Rule 10b5-1(c)"
Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.
IPO - Reserved Shares Program financial
"Purchase in IPO - Reserved Shares Program"
Aggregate Market Value financial
"Number of Shares or Other Units To Be Sold | Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RPRX shares did Christopher Hite report for sale?

Christopher Hite reported a proposed sale of 30,000 Class A ordinary shares, with an aggregate market value of $1,660,500 and an approximate sale date of June 23, 2026.

What plan is connected to Christopher Hite's proposed RPRX sale?

The proposed sale is connected to a selling plan dated March 20, 2026, which is intended to comply with Rule 10b5-1(c).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading